SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001309653-24-000002
Filing Date
2024-01-11
Accepted
2024-01-11 16:02:48
Documents
1
Period of Report
2024-01-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1705006959.html 4  
1 FORM 4 wk-form4_1705006959.xml 4 3382
  Complete submission text file 0001309653-24-000002.txt   5157
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Issuer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SUPERGEN, INC. 4140 DUBLIN BLVD., SUITE 200 DUBLIN CA 94568
Business Address
AZAB MOHAMMAD (Reporting) CIK: 0001309653 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33650 | Film No.: 24529265